HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Cuiting Peng Selected Research
Cuiting Peng Research Topics
Disease
9
Neoplasms (Cancer)
06/2022 - 02/2016
5
Neoplasm Metastasis (Metastasis)
06/2022 - 02/2016
2
Melanoma (Melanoma, Malignant)
06/2022 - 02/2016
2
Triple Negative Breast Neoplasms
01/2019 - 01/2018
1
Familial Abdominal 3 Aortic Aneurysm
01/2022
1
Thalassemia
01/2022
1
Homocysteinemia
12/2021
1
Methylmalonic acidemia
12/2021
1
Lymphoma (Lymphomas)
01/2021
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2019
1
Carcinogenesis
01/2019
1
Brain Neoplasms (Brain Tumor)
01/2019
1
Breast Neoplasms (Breast Cancer)
10/2018
1
Nervous System Diseases (Neurological Disorders)
02/2017
1
Cardiovascular Diseases (Cardiovascular Disease)
02/2017
1
Obesity
02/2017
1
Hematologic Neoplasms (Hematological Malignancy)
02/2017
1
Inflammation (Inflammations)
02/2017
1
Infections
01/2016
1
Bacterial Infections (Bacterial Infection)
01/2016
Drug/Important Bio-Agent (IBA)
2
nifuroxazide (Akabar)
IBA
06/2022 - 02/2016
2
Proteins (Proteins, Gene)
FDA Link
10/2019 - 02/2017
2
Antipsychotic Agents (Antipsychotics)
IBA
01/2019 - 01/2018
1
Globins
IBA
01/2022
1
Glycated Hemoglobin (Glycosylated Hemoglobin)
IBA
01/2022
1
Vitamin B 12 (Cyanocobalamin)
FDA Link
Generic
12/2021
1
Transcription Factors (Transcription Factor)
IBA
01/2021
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2021
1
Benzoxazines
IBA
10/2019
1
Fluphenazine (Prolixin)
FDA Link
Generic
01/2019
1
PDZ-binding kinase
IBA
01/2019
1
Mitogen-Activated Protein Kinases
IBA
01/2019
1
Protein Kinases (Protein Kinase)
IBA
01/2019
1
Phosphotransferases (Kinase)
IBA
10/2018
1
Caspase 3 (Caspase-3)
IBA
01/2018
1
Trifluoperazine (Stelazine)
FDA Link
Generic
01/2018
1
Benzenesulfonamides
IBA
02/2017
1
Vimentin
IBA
02/2016
1
Antidiarrheals
IBA
02/2016
1
Matrix Metalloproteinases (MMPs)
IBA
02/2016
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2016
1
2- (2- methyl- 1,4- dioxa- 8- azaspiro(4.5)dec- 8- yl)- 8- nitro- 6- (trifluoromethyl)- 4H- 1,3- benzothiazin- 4- one
IBA
01/2016
Therapy/Procedure
3
Therapeutics
10/2018 - 01/2016
2
Oral Administration
01/2019 - 10/2018
1
Drug Therapy (Chemotherapy)
10/2018